Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations

Autor: Cristofanilli, M. *, Morandi, P., Krishnamurthy, S., Reuben, J.M., Lee, B.-N., Francis, D., Booser, D.J., Green, M.C., Arun, B.K., Pusztai, L., Lopez, A., Islam, R., Valero, V., Hortobagyi, G.N.
Zdroj: In Annals of Oncology October 2008 19(10):1713-1719
Databáze: ScienceDirect